Stifel Sees 5 Reasons to be Positive on Ultragenyx Pharma's (RARE) GTX-102
Tweet Send to a Friend
Stifel analyst Dae Gon Ha reiterated a Buy rating and $179.00 price target on Ultragenyx Pharma (NASDAQ: RARE) ahead of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
